Conference Presentations
and Journal Articles
See the different areas that the Princeton Pharmatech team has researched and published in over the years and their accomplishments in those studies.
Conference Presentations
Conference PresentationTreatment Persistence Among Amyotrophic Lateral Sclerosis Patients Receiving Intravenous Edaravone: Results from a National Infusion Center
Melissa Hagan PhD; Malgorzata Ciepielewska MS: Antoinette Harrison PharmD BCPP BCGP FASCP; Ying Liu PhD; Jeffrey Zhang PhD; Barbara Prosser RPh; Stephen Apple MD
December 2020
Conference PresentationReal-World Treatment Patterns in Amyotrophic Lateral Sclerosis Patients Treated With IV Edaravone: 12-Months of Follow-up in Patients Receiving Treatment From a National Infusion Center
Melissa Hagan PhD MPH; Antoinette Harrison PharmD BCPP BCGP FASCP; Malgorzata Ciepielewska MS; Ying Liu PhD; Jeffrey Zhang PhD; Barbara Prosser RPh; Stephen Apple MD
October 2020
Conference PresentationDemographic and Clinical Characteristics in Amyotrophic Lateral Sclerosis Patients Treated With IV Edaravone: Results From a US Administrative Claims Database
Melissa Hagan PhD MPH; Antoinette Harrison PharmD BCPP BCGP FASCP; Malgorzata Ciepielewska MS; Jeffrey Zhang PhD; Ying Liu PhD; Stephen Apple MD
October 2020
Conference PresentationPost Hoc Analysis of Edaravone Study 19: Efficacy in Bulbar Onset ALS Patients With and Without Reduced Pulmonary Function
Gary Pattee MD; Gustavo Suarez Zambrano MD; Jeffrey Zhang PhD; Sally Nelson MS PhD; Stephen Apple MD
October 2020
Journal ArticleAuxora versus standard of care for the treatment of severe or critical COVID-19 pneumonia: results from a randomized controlled trial
Joseph Miller, Charles Bruen, Michael Schnaus, Jeffrey Zhang, Sadia Ali, April Lind, Zachary Stoecker, Kenneth Stauderman and Sudarshan Hebbar
August 2020